Основная статистика
| LEI | 0W9AIBT6U6ADJ2I8HK17 |
| CIK | 70318 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Tenet Healthcare Corporation
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| July 30, 2025 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2025 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| July 30, 2025 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| July 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 22, 2025 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emplo |
|
| July 22, 2025 |
Tenet Reports Strong Second Quarter 2025 Results; Raises 2025 Financial Outlook Exhibit 99.1 Tenet Reports Strong Second Quarter 2025 Results; Raises 2025 Financial Outlook •Net income available to common shareholders in second quarter 2025 was $288 million, or $3.14 per diluted share •Adjusted diluted earnings per share1 increased 74% to $4.02 in second quarter 2025 compared to $2.31 in second quarter 2024 •Consolidated Adjusted EBITDA1 in second quarter 2025 increased 18.6% |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 30, 2025 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| May 27, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 22, 2025 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| April 29, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 29, 2025 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| April 29, 2025 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| April 29, 2025 |
Tenet Reports Strong First Quarter 2025 Results Exhibit 99.1 Tenet Reports Strong First Quarter 2025 Results •Net income available to common shareholders in first quarter 2025 was $406 million, or $4.27 per diluted share •Adjusted diluted earnings per share1 increased 35.4% to $4.36 in first quarter 2025 compared to $3.22 in first quarter 2024 •Consolidated Adjusted EBITDA1 in first quarter 2025 increased 13.6% to $1.163 billion compared to fir |
|
| April 29, 2025 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| April 17, 2025 |
Notice of Exempt Solicitation Pursuant to Rule 14a-103 PX14A6G 1 y417250px14a6g.htm Notice of Exempt Solicitation Pursuant to Rule 14a-103 Name of Registrant: Tenet Healthcare Corporation (THC) Name of person relying on exemption: John Chevedden, Tenet Shareholder since 2021 Address of persons relying on exemption: POB 2673, Redondo Beach, CA 90278 These written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exch |
|
| April 11, 2025 |
DEFA14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 11, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| February 18, 2025 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| February 18, 2025 |
Consolidated Subsidiaries of the Registrant Exhibit 21 Consolidated Subsidiaries of Tenet Healthcare Corporation as of December 31, 2024 Name of Entity State or Other Jurisdiction of Formation 601 N 30th Street I, L. |
|
| February 18, 2025 |
Insider Trading Policy and Procedures of the Registrant Exhibit 19 CORPORATE POLICY Manual/Library Name: Law No: ADO.05.01 Page: 1 of 3 Effective Date: 04/02/24 Policy Title: Insider Trading (AD 1.18) Previous Versions: 07/30/19; 06/27/13; 09/07/10; 05/01/10; 02/20/10 Approved By: Executive Leadership Team Approval Date: 03/04/24 I.Scope: This policy applies to individuals associated with the following entities collectively referred to herein as “Tenet |
|
| February 18, 2025 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| February 18, 2025 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4(a) DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2024, Tenet Healthcare Corporation (the “Company,” “we,” “our” or “us”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (1) common stock; and (2) 6. |
|
| February 18, 2025 |
Exhibit 10(ll) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| February 12, 2025 |
Tenet Reports Strong Fourth Quarter and FY 2024 Results; Provides 2025 Financial Outlook Exhibit 99.1 Tenet Reports Strong Fourth Quarter and FY 2024 Results; Provides 2025 Financial Outlook •Net income available to common shareholders in fourth quarter 2024 was $318 million, or $3.32 per diluted share •Adjusted diluted earnings per share1 was $3.44 in fourth quarter 2024 •Consolidated Adjusted EBITDA1 in fourth quarter 2024 was $1.048 billion, which represents an Adjusted EBITDA marg |
|
| February 12, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 12, 2025 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS E |
|
| January 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 23, 2025 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Em |
|
| January 24, 2025 |
Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is hereby entered into to be effective from and following January 23, 2025 (the “Effective Date”), between Tenet Healthcare Corporation (the “Company”) and Saumya Sutaria (“Executive”). W I T N E S S E T H WHEREAS, the Company and Executive are party to that certain Employment A |
|
| November 14, 2024 |
THC / Tenet Healthcare Corporation / GLENVIEW CAPITAL MANAGEMENT, LLC Passive Investment SC 13G/A 1 sc13gano4thc.htm SC 13G 1 ef20018944sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* TENET HEALTHCARE CORPORATION (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of Securities) 88033G407 (CUSIP Number) September 30, 2024 (Date of Event which Requires |
|
| October 29, 2024 |
Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook Exhibit 99.1 Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook •Net income available to common shareholders in third quarter 2024 was $472 million, or $4.89 per diluted share, including an after-tax gain of $209 million, or $2.16 per diluted share, primarily associated with previously announced hospital divestitures •Adjusted diluted earnings per share1 was $2.93 in th |
|
| October 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2024 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| October 29, 2024 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| October 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 29, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Em |
|
| October 29, 2024 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| August 5, 2024 |
Exhibit 99.1 Tenet Healthcare to Sell Five Birmingham Hospitals to Orlando Health Tenet announces agreement to sell Birmingham hospitals and related operations; reaffirms latest FY24 Adjusted EBITDA Outlook DALLAS — August 5, 2024 — Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Orlando Health for the sale of Tenet’s 70% majority ownership interest in Brookwo |
|
| August 5, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 5, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| July 30, 2024 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| July 30, 2024 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| July 30, 2024 |
Exhibit 10(a) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS FOR ANNUAL GRANT TO DIRECTORS The Human Resources Committee (the “Committee”) of the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”) to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2024 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| July 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 24, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emplo |
|
| July 24, 2024 |
Tenet Reports Strong Second Quarter 2024 Results; Raises 2024 Financial Outlook Exhibit 99.1 Tenet Reports Strong Second Quarter 2024 Results; Raises 2024 Financial Outlook •Net income available to common shareholders in second quarter 2024 was $259 million, or $2.64 per diluted share •Adjusted diluted earnings per share1 was $2.31 in second quarter 2024 •Consolidated Adjusted EBITDA1 in second quarter 2024 of $945 million increased 12.1% over second quarter 2023 •Second quar |
|
| May 23, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 22, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| May 14, 2024 |
United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103 Name of the Registrant: Tenet Healthcare Corporation Name of persons relying on exemption: Rhia Ventures Address of persons relying on exemption: 47 Kearny Street, San Francisco, CA 94108 Written materials are submitted pursuant to Rule 14a-6(g) (1) promulgated under the S |
|
| April 30, 2024 |
Exhibit 10(b) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| April 30, 2024 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| April 30, 2024 |
Exhibit 10(a) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| April 30, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 30, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| April 30, 2024 |
Tenet Reports First Quarter 2024 Results Well in Excess of Guidance; Raises 2024 Financial Outlook Exhibit 99.1 Tenet Reports First Quarter 2024 Results Well in Excess of Guidance; Raises 2024 Financial Outlook •Net income from continuing operations available to common shareholders in first quarter 2024 was $2.151 billion, or $21.38 per diluted share, including an after-tax gain of $1.856 billion, or $18.45 per diluted share, associated with previously announced hospital divestitures •Adjusted |
|
| April 30, 2024 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| April 12, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 12, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 1, 2024 |
Tenet Completes Sale of Six Hospitals in California Exhibit 99.1 Tenet Completes Sale of Six Hospitals in California DALLAS – April 1, 2024 -Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of six hospitals and related operations in California consistent with previously disclosed terms. Tenet completed the sale of its four Orange County and Los Angeles County hospitals and related operations to UCI Health – co |
|
| April 1, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 1, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emplo |
|
| February 29, 2024 |
Exhibit 99.1 Tenet to Sell Two Hospitals and Enter into a Revenue Cycle Services Partnership with Adventist Health Tenet announces agreement to sell San Luis Obispo County hospitals and related operations as well as a new health system partnership for Conifer Health Solutions DALLAS—February 29, 2024 —Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Adventist H |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 29, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS E |
|
| February 16, 2024 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4(a) DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, Tenet Healthcare Corporation (the “Company,” “we,” “our” or “us”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (1) common stock; and (2) 6. |
|
| February 16, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 16, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS E |
|
| February 16, 2024 |
Tenet Healthcare Corporation Clawback Policy Exhibit 97 Tenet Healthcare Corporation CLAWBACK POLICY Recoupment of Incentive-Based Compensation It is the policy of Tenet Healthcare Corporation (the “Company”) that, in the event the Company is required to prepare an accounting restatement of the Company’s financial statements due to material non-compliance with any financial reporting requirement under the federal securities laws (including a |
|
| February 16, 2024 |
Exhibit 10(ee) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS FOR INITIAL GRANT TO DIRECTORS PRIOR TO MAY 2021 The Compensation Committee (the ”Committee”) of the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”) to make awards of restricted stock units ("RSUs") and to determine the terms of such RSUs. |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| February 16, 2024 |
Exhibit 10(l) EIGHTH AMENDMENT TO STOCK PLEDGE AGREEMENT This Eighth Amendment to Stock Pledge Agreement (this “Amendment”) is entered into as of August 26, 2019, among Tenet Healthcare Corporation, a Nevada corporation (the “Company”), each of the other entities listed on the signature pages hereof as Pledgors, and The Bank of New York Mellon Trust Company, N. |
|
| February 16, 2024 |
Certification of Sun Park, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Sun Park, certify that: 1. |
|
| February 16, 2024 |
Exhibit 10(ff) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS FOR ANNUAL GRANT TO DIRECTORS The Human Resources Committee (the ”Committee”) of the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”) to make awards of restricted stock units ("RSUs") and to determine the terms of such RSUs. |
|
| February 16, 2024 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| February 16, 2024 |
Tenet Calls for Full Redemption of 4.875% Senior Secured First Lien Notes due 2026 Exhibit 99.1 Tenet Calls for Full Redemption of 4.875% Senior Secured First Lien Notes due 2026 DALLAS – February 16, 2024 – Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all $2,100 million outstanding of its 4.875% Senior Secured First Lien Notes due 2026 (the “Notes”), which were issued pursuant to the Indenture, dated as of November 6, 2001 (the “Base Indenture”), |
|
| February 16, 2024 |
Consolidated Subsidiaries of the Registrant Exhibit 21 Consolidated Subsidiaries of Tenet Healthcare Corporation as of December 31, 2023 Name of Entity State or Other Jurisdiction of Formation 601 N 30th Street I, L. |
|
| February 14, 2024 |
THC / Tenet Healthcare Corporation / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 12)* TENET HEALTHCARE CORP (Name of Issuer) Common stock, $0.05 par value (Title of Class of Securities) 88033G407 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs |
|
| February 14, 2024 |
THC / Tenet Healthcare Corporation / GLENVIEW CAPITAL MANAGEMENT, LLC Passive Investment SC 13G/A 1 sayw2402142613ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* TENET HEALTHCARE CORPORATION (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of Securities) 88033G407 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check |
|
| February 13, 2024 |
THC / Tenet Healthcare Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv02054-tenethealthcarecorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* Name of issuer: Tenet Healthcare Corp Title of Class of Securities: Common Stock CUSIP Number: 88033G407 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to d |
|
| February 9, 2024 |
THC / Tenet Healthcare Corporation / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Tenet Healthcare Corp (Name of Issuer) Common Stock (Title of Class of Securities) 88033G407 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 9, 2024 |
EX-99 2 Rule13DJointFilingAgreement.htm JOINT FILING AGREEMENT JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd., as the ultimate parent company of each of its undersigned subsidiarie |
|
| February 8, 2024 |
Tenet Reports Fourth Quarter and FY 2023 Results; Provides 2024 Financial Outlook Exhibit 99.1 Tenet Reports Fourth Quarter and FY 2023 Results; Provides 2024 Financial Outlook •Net income from continuing operations available to common shareholders in fourth quarter 2023 was $244 million, or $2.30 per diluted share •Adjusted diluted earnings per share from continuing operations1 was $2.68 in fourth quarter 2023 •Consolidated Adjusted EBITDA1 in fourth quarter 2023 of $1.012 bil |
|
| February 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 8, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Em |
|
| February 1, 2024 |
TENET HEALTHCARE CORPORATION UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 TENET HEALTHCARE CORPORATION UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The following unaudited pro forma condensed consolidated financial statements are based on the Company's historical consolidated results of operations and financial position, adjusted to give effect to the Transaction, as defined in Item 2.01 of this Form 8-K, as if it had been completed on Se |
|
| February 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 1, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Em |
|
| February 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 1, 2024 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Em |
|
| February 1, 2024 |
Exhibit 99.1 Tenet Advances Portfolio Transformation and Previews Strong 2023 Results Tenet completes sale of three South Carolina hospitals and announces the sale of four Orange County and Los Angeles County hospitals and related operations. DALLAS - February 1, 2024 -Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of three of its hospitals and related oper |
|
| December 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 11, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS E |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 17, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS E |
|
| November 17, 2023 |
Tenet Healthcare to Sell Three South Carolina Hospitals to Novant Health Exhibit 99.1 Tenet Healthcare to Sell Three South Carolina Hospitals to Novant Health Dallas, TX – November 17, 2023 – Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Novant Health for the sale of three Tenet hospitals and related operations in South Carolina for approximately $2.4 billion in cash (after-tax proceeds of approximately $1.750 billion). The trans |
|
| October 30, 2023 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| October 30, 2023 |
Exhibit 10(b) RETIREMENT AGREEMENT AND GENERAL RELEASE This Retirement Agreement and General Release (this "Agreement") is entered into by and among Tenet Healthcare Corporation (“Tenet”), Tenet Business Services Corporation (the “Company”) and Dan Cancelmi (“Executive”) who agree as follows: 1. |
|
| October 30, 2023 |
Tenet Reports Third Quarter 2023 Results; Raises 2023 Outlook Exhibit 99.1 Tenet Reports Third Quarter 2023 Results; Raises 2023 Outlook •Net income from continuing operations available to common shareholders in third quarter 2023 was $101 million, or $0.94 per diluted share •Adjusted diluted earnings per share from continuing operations1 was $1.44 in third quarter 2023 •Consolidated Adjusted EBITDA1 in third quarter 2023 was $854 million, including $3 milli |
|
| October 30, 2023 |
Exhibit 10(c) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| October 30, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 30, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Em |
|
| October 30, 2023 |
Certification of Saumya Sutaria, M.D., Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| October 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| September 8, 2023 |
Exhibit 10.1 AMENDMENT NO. 6 (this “Amendment”) dated as of September 7, 2023, among TENET HEALTHCARE CORPORATION, a Nevada corporation (the “Company”), the Subsidiaries of the Company party hereto, the LC Participants and Issuers party hereto and BARCLAYS BANK PLC, as administrative agent (the “Administrative Agent”) under the Letter of Credit Facility Agreement, dated as of March 7, 2014, among |
|
| September 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 7, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emp |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 19, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 9, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| July 31, 2023 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| July 31, 2023 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| July 31, 2023 |
Letter from the Registrant to Sun Park, dated as of June 3, 2023* Exhibit 10(a) June 3, 2023 Sun Park [Address Omitted] [Address Omitted] RE: Position of Executive Vice President, Chief Financial Officer Dear Sun, I am delighted to offer you the position of Executive Vice President, Chief Financial Officer with Tenet Healthcare (the Company). |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 31, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| July 31, 2023 |
Tenet Reports Second Quarter 2023 Results; Raises 2023 Outlook Exhibit 99.1 Tenet Reports Second Quarter 2023 Results; Raises 2023 Outlook •Net income from continuing operations available to common shareholders in second quarter 2023 was $123 million, or $1.15 per diluted share •Adjusted diluted earnings per share from continuing operations1 was $1.44 in second quarter 2023 •Consolidated Adjusted EBITDA1 in second quarter 2023 was $843 million, including $8 m |
|
| June 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 23, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emplo |
|
| June 23, 2023 |
Tenet Announces Chief Financial Officer Transition Exhibit 99.1 Tenet Announces Chief Financial Officer Transition DALLAS – June 23, 2023 – Tenet Healthcare Corporation (NYSE: THC) announced the appointment of Sun Park as Executive Vice President & Chief Financial Officer of the Company, effective January 1, 2024, as part of the Company’s planned Chief Financial Officer transition. Mr. Park will serve as an Executive Vice President of the Company |
|
| May 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 25, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| May 25, 2023 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 25, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| May 16, 2023 |
EX-4.2 Exhibit 4.2 TENET HEALTHCARE CORPORATION AND THE GUARANTORS FROM TIME TO TIME PARTY HERETO Fortieth Supplemental Indenture Dated as of May 16, 2023 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 6.750% Senior Secured First Lien Notes Due 2031 TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 16, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employer |
|
| May 8, 2023 |
United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103 Name of the Registrant: Tenet Healthcare Corporation Name of persons relying on exemption: Rhia Ventures Address of persons relying on exemption: 47 Kearny Street, San Francisco, CA 94108 Written materials are submitted pursuant to Rule 14a-6(g) (1) promulgated under the S |
|
| May 2, 2023 |
Tenet Announces Pricing of its $1.350 Billion Private Offering of Senior Secured Notes Exhibit 99.2 Tenet Announces Pricing of its $1.350 Billion Private Offering of Senior Secured Notes DALLAS – May 2, 2023 – Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.350 billion in aggregate principal amount of senior secured first lien notes due on May 15, 2031, which will bear int |
|
| May 2, 2023 |
Tenet Announces $1.350 Billion Private Offering of Senior Secured Notes Exhibit 99.1 Tenet Announces $1.350 Billion Private Offering of Senior Secured Notes DALLAS – May 2, 2023 – Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.350 billion in aggregate principal amount of new senior secured first lien notes maturing in 2031 (the “notes”). Completion of the notes offering is subject to, among other things, pricing and customa |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 2, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employer Identification Number) 14201 Dallas Parkway Dallas, TX 75254 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0. |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada (State of Incorporation) 95-2557091 (IRS Employer Identification No. |
|
| April 28, 2023 |
Exhibit 10(b) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| April 28, 2023 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| April 28, 2023 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| April 28, 2023 |
Exhibit 10(a) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| April 25, 2023 |
Tenet Reports First Quarter 2023 Results; Raises 2023 Outlook Exhibit 99.1 Tenet Reports First Quarter 2023 Results; Raises 2023 Outlook •Net income from continuing operations available to common shareholders in first quarter 2023 was $143 million, or $1.32 per diluted share •Adjusted diluted earnings per share from continuing operations1 of $1.42 in first quarter 2023 •Consolidated Adjusted EBITDA1 in first quarter 2023 of $832 million, including $3 million |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 25, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| April 17, 2023 |
United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103 Name of the Registrant: Tenet Healthcare Corporation Name of persons relying on exemption: Rhia Ventures Address of persons relying on exemption: 47 Kearny Street, San Francisco, CA 94108 Written materials are submitted pursuant to Rule 14a-6(g) (1) promulgated under the S |
|
| April 14, 2023 |
DEFA14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 14, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| February 21, 2023 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| February 21, 2023 |
Exhibit 10(mm) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units and to determine the terms of such restricted stock units. |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| February 21, 2023 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4(a) DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, Tenet Healthcare Corporation (the “Company,” “we,” “our” or “us”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (1) common stock; and (2) 6. |
|
| February 21, 2023 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this annual report on Form 10-K of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which |
|
| February 21, 2023 |
Exhibit 10(ss) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| February 21, 2023 |
Exhibit 10(y) February 18, 2022 Lisa Foo [Address Omitted] [Address Omitted] RE: Position of Executive Vice President, Commercial Operations Dear Lisa, I am delighted to promote you to the position of Executive Vice President, Commercial Operations with Tenet Healthcare (the Company). |
|
| February 21, 2023 |
Exhibit 10(ll) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS FOR ANNUAL GRANT TO DIRECTORS The Human Resources Committee (the “Committee”) of the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”) to make awards of restricted stock units (“RSUs”) and to determine the terms of such RSUs. |
|
| February 21, 2023 |
Consolidated Subsidiaries of the Registrant Exhibit 21 Consolidated Subsidiaries of Tenet Healthcare Corporation as of December 31, 2022 Name of Entity State or Other Jurisdiction of Formation 601 N 30th Street I, L. |
|
| February 14, 2023 |
THC / Tenet Healthcare Corp / HARRIS ASSOCIATES L P Passive Investment SC 13G/A 1 formsc13ga-02142023090215.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 11)* Tenet Healthcare Corporation (Name of Issuer) Common stock, $0.05 par value (Title of Class of Securities) 88033G407 (CUSIP Number) December 31 , 2022 (Date of Event Which Requires Filing of this Statement) Che |
|
| February 14, 2023 |
THC / Tenet Healthcare Corp / GLENVIEW CAPITAL MANAGEMENT, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* TENET HEALTHCARE CORPORATION (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of Securities) 88033G407 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate |
|
| February 9, 2023 |
Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook Exhibit 99.1 Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook •Net income from continuing operations available to common shareholders in fourth quarter 2022 was $102 million, or $0.92 per diluted share •Adjusted diluted earnings per share from continuing operations1 of $1.96 in fourth quarter 2022 •Consolidated Adjusted EBITDA1 in fourth quarter 2022 of $897 millio |
|
| February 9, 2023 |
THC / Tenet Healthcare Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Tenet Healthcare Corp. Title of Class of Securities: Common Stock CUSIP Number: 88033G407 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| February 9, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 9, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| February 8, 2023 |
THC / Tenet Healthcare Corp / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Tenet Healthcare Corp (Name of Issuer) Common Stock (Title of Class of Securities) 88033G407 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| January 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 19, 2023 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| January 19, 2023 |
Tenet Anticipates Beating Midpoint of Latest 2022 Outlook; Announces Key Leadership Updates Exhibit 99.1 Tenet Anticipates Beating Midpoint of Latest 2022 Outlook; Announces Key Leadership Updates DALLAS – January 19, 2023 – Tenet Healthcare Corporation (Tenet) (NYSE: THC) announced today that it expects to exceed the midpoint of its latest FY22 Adjusted EBITDA Outlook range included in its third quarter 2022 earnings release along with key leadership updates that will help support long- |
|
| October 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2022 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| October 28, 2022 |
Exhibit 10(b) TENET SPECIAL RSU DEFERRAL PLAN Amended and Restated Effective August 10, 2022 TABLE OF CONTENTS TENET SPECIAL RSU DEFERRAL PLAN Page ARTICLE I PREAMBLE AND PURPOSE 1 1. |
|
| October 28, 2022 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| October 28, 2022 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| October 20, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 20, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| October 20, 2022 |
Tenet Reports Third Quarter 2022 Results; Announces $1 Billion Share Repurchase Program Exhibit 99.1 Tenet Reports Third Quarter 2022 Results; Announces $1 Billion Share Repurchase Program ?Net income from continuing operations available to common shareholders in third quarter 2022 was $131 million, or $1.16 per diluted share ?Adjusted diluted earnings per share from continuing operations1 of $1.44 in third quarter 2022 ?Consolidated Adjusted EBITDA1 in third quarter 2022 of $841 mil |
|
| October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 1, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emplo |
|
| October 3, 2022 |
Exhibit 10.1 Execution Version TENET HEALTHCARE CORPORATION October 1, 2022 Ronald A. Rittenmeyer BY HAND Re: Disability Resignation Dear Ron, Reference is made to that certain Amended and Restated Employment Agreement by and between you and Tenet Healthcare Corporation (the ?Company?), dated as of September 1, 2021, as amended on February 25, 2022 (the ?Employment Agreement?). Capitalized terms u |
|
| August 15, 2022 |
As filed with the Securities and Exchange Commission on August 15, 2022 As filed with the Securities and Exchange Commission on August 15, 2022 Registration No. |
|
| August 15, 2022 |
Exhibit 24.1 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints each of Thomas Arnst, Daniel Cancelmi and Chad Wiener, acting alone, as his or her true and lawful attorneys-in-fact and agents, with full power of resubstitution and substitution, for him or her and in his or her name, place and stead, in any and all capaci |
|
| August 15, 2022 |
Exhibit 107.1 Calculation of Filing Fee Tables FORM S-8 (Form Type) TENET HEALTHCARE CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title (1) Fee Calculation Rule (2) Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock |
|
| July 29, 2022 |
Exhibit 10(b) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN (AS AMENDED BY THE FIRST AMENDMENT THERETO) Tenet Healthcare Corporation (the ?Company?), a Nevada corporation, hereby establishes and adopts the following Tenet Healthcare 2019 Stock Incentive Plan (as amended from time to time, the ?Plan?). |
|
| July 29, 2022 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| July 29, 2022 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2022 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| July 21, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 21, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| July 21, 2022 |
Tenet Reports Second Quarter 2022 Results; Reaffirms 2022 Adjusted EBITDA Outlook Exhibit 99.1 Tenet Reports Second Quarter 2022 Results; Reaffirms 2022 Adjusted EBITDA Outlook ?Net income from continuing operations available to common shareholders in Q2?22 of $38 million versus $120 million in Q2?21 ?Consolidated Adjusted EBITDA in Q2?22 of $843 million versus $834 million in Q2?21 ?Q2'22 USPI Adjusted EBITDA grew 15.3 percent over Q2'21 excluding grant income; Same-facility s |
|
| June 15, 2022 |
Exhibit 4.2 TENET HEALTHCARE CORPORATION AND THE GUARANTORS FROM TIME TO TIME PARTY HERETO Thirty-Ninth Supplemental Indenture Dated as of June 15, 2022 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 6.125% Senior Secured First Lien Notes Due 2030 TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS OF G |
|
| June 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 15, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| June 15, 2022 |
Exhibit 10.1 TENET HEALTHCARE CORPORATION $2,000,000,000 6.125% Senior Secured First Lien Notes due 2030 unconditionally guaranteed as to the payment of principal, premium, if any, and interest by the Guarantors named on Schedule I hereto Exchange and Registration Rights Agreement June 15, 2022 Barclays Capital Inc. 745 Seventh Avenue New York, NY 10019 As Representative of the Initial Purchasers |
|
| June 1, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 1, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employer |
|
| June 1, 2022 |
Tenet Announces $1.800 Billion Private Offering of Senior Secured Notes Exhibit 99.1 Tenet Announces $1.800 Billion Private Offering of Senior Secured Notes DALLAS ? June 1, 2022 ? Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.800 billion in aggregate principal amount of new senior secured first lien notes maturing in 2030 (the ?notes?). Completion of the notes offering is subject to, among other things, pricing and custom |
|
| June 1, 2022 |
Tenet Announces Upsizing and Pricing of its $2.000 Billion Private Offering of Senior Secured Notes Exhibit 99.2 Tenet Announces Upsizing and Pricing of its $2.000 Billion Private Offering of Senior Secured Notes DALLAS ? June 1, 2022 ? Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.000 billion in aggregate principal amount of senior secured first lien notes due on June 15, 2030, whic |
|
| May 9, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 6, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employer Identification Number) 14201 Dallas Parkway Dallas, TX 75254 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant?s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0. |
|
| April 29, 2022 |
Amendment No. 1 to Amended and Restated Employment Agreement between the Registrant and Ronald Exhibit 10(b) AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 (this ?Amendment No. 1?), dated as of February 25, 2022 (the ?Effective Date?), is entered into between Ronald A. Rittenmeyer (the ?Executive?) and Tenet Healthcare Corporation (the ?Company?). RECITALS WHEREAS, the Company and the Executive are parties to that certain Amended and Restated Employment Ag |
|
| April 29, 2022 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| April 29, 2022 |
Exhibit 10(d) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the ?Committee?) of the Board of Directors of Tenet Healthcare Corporation (the ?Company?) is authorized under the Company?s 2019 Stock Incentive Plan, as such may be amended from time to time (the ?Plan?), to make awards of restricted stock units (?RSUs?) and to determine the terms of such RSUs. |
|
| April 29, 2022 |
Exhibit 10(f) AMENDMENT TO RETIREMENT AGREEMENT AND GENERAL RELEASE This Amendment (this ?Amendment?) is entered into by and among Tenet Healthcare Corporation (?Tenet?), Tenet Business Services Corporation (the ?Company?) and Audrey Andrews ("Executive") and amends that certain Retirement Agreement and General Release (the "Agreement") entered into by and among Tenet, the Company and Executive entered into on December 30, 2021. |
|
| April 29, 2022 |
Exhibit 10(c) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the ?Committee?) of the Board of Directors of Tenet Healthcare Corporation (the ?Company?) is authorized under the Company?s 2019 Stock Incentive Plan, as such may be amended from time to time (the ?Plan?), to make awards of restricted stock units (?RSUs?) and to determine the terms of such RSUs. |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2022 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| April 29, 2022 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the ?Registrant?); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| April 29, 2022 |
Exhibit 10(e) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the ?Committee?) of the Board of Directors of Tenet Healthcare Corporation (the ?Company?) is authorized under the Company?s 2019 Stock Incentive Plan, as such may be amended from time to time (the ?Plan?), to make awards of restricted stock units (?RSUs?) and to determine the terms of such RSUs. |
|
| April 20, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 20, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| April 20, 2022 |
Exhibit 99.1 Tenet Reports First Quarter 2022 Results; Retired over $800 Million of Debt To Date in 2022; Maintains 2022 Adjusted EBITDA Outlook ?Net income from continuing operations available to common shareholders in Q1?22 of $139 million ($135 million excluding grant income) versus net income from continuing operations of $97 million in Q1?21 ($73 million excluding grant income) ?Consolidated |
|
| March 25, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 16, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| March 17, 2022 |
Tenet Announces Amendment to its Credit Agreement Exhibit 99.1 Tenet Announces Amendment to its Credit Agreement DALLAS ? March 17, 2022 ? Tenet Healthcare Corporation (NYSE: THC) today announced that it has entered into an amendment to its existing senior secured revolving credit facility. The amendment has an effective date of March 16, 2022 and amends certain provisions under the credit agreement to, among other things, (i) provide for aggrega |
|
| March 17, 2022 |
Exhibit 10.1 Execution Version AMENDMENT NO. 7 This AMENDMENT NO. 7, dated as of March 16, 2022 (together with all exhibits and schedules hereto, this ?Amendment?) to that certain Amended and Restated Credit Agreement, dated as of October 19, 2010 (as amended, restated, amended and restated, supplemented or otherwise modified through the date hereof, the ?Existing Credit Agreement?) among Tenet He |
|
| March 1, 2022 |
Exhibit 99.1 Conifer to Remain Part of Tenet with Strong Path Forward Conference call scheduled for today, March 1, at 10:00 a.m. Eastern Time (9:00 Central Time) DALLAS ? March 1, 2022 ? Tenet Healthcare Corporation (NYSE: THC) announced today that ? based on ongoing shareholder value creation opportunities and improved business fundamentals ? the Company will no longer pursue a spinoff of its Co |
|
| March 1, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 1, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 25, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS E |
|
| February 25, 2022 |
Exhibit 10.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 (this ?Amendment No. 1?), dated as of February 25, 2022 (the ?Effective Date?), is entered into between Ronald A. Rittenmeyer (the ?Executive?) and Tenet Healthcare Corporation (the ?Company?). RECITALS WHEREAS, the Company and the Executive are parties to that certain Amended and Restated Employment Agr |
|
| February 18, 2022 |
Certification of Saumya Sutaria Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| February 18, 2022 |
EX-10.LL 7 thc-20211231ex10ll.htm EX-10.LL Exhibit 10(ll) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as amended (the “Plan”), to make awards of restricted stock uni |
|
| February 18, 2022 |
EX-10.OO 10 thc-20211231ex10oo.htm EX-10.OO Exhibit 10(oo) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make |
|
| February 18, 2022 |
EX-10.KK 6 thc-20211231ex10kk.htm EX-10.KK Exhibit 10(kk) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS The Human Resources Committee (the “Committee”) of the Board of Directors of Tenet Healthcare Corporation (the “Company”) is authorized under the Company’s 2019 Stock Incentive Plan, as such may be amended from time to time (the “Plan”), to make |
|
| February 18, 2022 |
Exhibit 10(nn) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS The Human Resources Committee (the ?Committee?) of the Board of Directors of Tenet Healthcare Corporation (the ?Company?) is authorized under the Company?s 2019 Stock Incentive Plan, as such may be amended from time to time (the ?Plan?), to make awards of restricted stock units and to determine the terms of such restricted stock units. |
|
| February 18, 2022 |
Exhibit 10(u) RETIREMENT AGREEMENT AND GENERAL RELEASE This Retirement Agreement and General Release (this ?Agreement?) is entered into by and among Tenet Healthcare Corporation (?Tenet?), Tenet Business Services Corporation (the ?Company?) and Audrey Andrews (?Executive?) who agree as follows: 1. |
|
| February 18, 2022 |
Consolidated Subsidiaries of the Registrant Exhibit 21 Consolidated Subsidiaries of Tenet Healthcare Corporation as of December 31, 2021 Name of Entity State or Other Jurisdiction of Formation 601 N 30th Street I, L. |
|
| February 18, 2022 |
Exhibit 10(w) Offer of Employment (Amended and Restated as of February 2, 2022) We are excited to offer you the following position with Tenet Healthcare (Tenet or the Company): ?Position: Executive Vice President and Chief Administrative Officer at the Company headquarters located in Dallas, TX, where you will report to Saum Sutaria, M. |
|
| February 18, 2022 |
Exhibit 10(y) TENET HEALTHCARE CORPORATION [Date] [Covered Executive] By Email Re: Amendment to Executive Severance Plan Agreement Dear [Covered Executive], This letter is intended to confirm our mutual understanding with respect to an amendment to the Tenet Executive Severance Plan Agreement (the ?Agreement?) by and between you and Tenet Healthcare Corporation (?Tenet?) regarding your participation in the Tenet Executive Severance Plan (the ?ESP?). |
|
| February 18, 2022 |
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4(a) DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2021, Tenet Healthcare Corporation (the ?Company,? ?we,? ?our? or ?us?) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): (1) common stock; and (2) 6. |
|
| February 18, 2022 |
EX-10.QQ 11 thc-20211231ex10qq.htm EX-10.QQ Exhibit 10(qq) SIXTH AMENDED TENET HEALTHCARE CORPORATION ANNUAL INCENTIVE PLAN (As Amended and Restated Effective November 3, 2021) 1.Purpose The purpose of this Tenet Healthcare Corporation Annual Incentive Plan is to provide incentives to enhance shareholder value and promote the attainment of significant business objectives of the Company by basing a |
|
| February 18, 2022 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this annual report on Form 10-K of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| February 18, 2022 |
Exhibit 10(mm) TENET HEALTHCARE 2019 STOCK INCENTIVE PLAN TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD The Human Resources Committee (the ?Committee?) of the Board of Directors of Tenet Healthcare Corporation (the ?Company?) is authorized under the Company?s 2019 Stock Incentive Plan (the ?Plan?) to make awards of restricted stock units (?RSUs?) and to determine the terms of such RSUs. |
|
| February 14, 2022 |
THC / Tenet Healthcare Corp / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Tenet Healthcare Corp (Name of Issuer) Common Stock (Title of Class of Securities) 88033G407 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc |
|
| February 14, 2022 |
JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) (l) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing of the attached Schedule 13G, and any and all amendments thereto, and expressly authorize Invesco Ltd. |
|
| February 14, 2022 |
THC / Tenet Healthcare Corp / GLENVIEW CAPITAL MANAGEMENT, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* TENET HEALTHCARE CORPORATION (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of Securities) 88033G407 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate |
|
| February 11, 2022 |
THC / Tenet Healthcare Corp / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* TENET HEALTHCARE CORP (Name of Issuer) Common Stock (Title of Class of Securities) 88033G407 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 10, 2022 |
THC / Tenet Healthcare Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Tenet Healthcare Corp. Title of Class of Securities: Common Stock CUSIP Number: 88033G407 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| February 7, 2022 |
EX-99.1 2 thc-20211231ex991earningsr.htm EX-99.1 Exhibit 99.1 Tenet Reports Strong Fourth Quarter and FY 2021 Results; Announces Plan to Retire $700 Million of Debt; Provides Detailed 2022 Financial Outlook •Net income from continuing operations available to common shareholders in Q4’21 of $250 million ($153 million excluding grant income) versus net income from continuing operations of $414 milli |
|
| February 7, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 7, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| January 11, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 11, 2022 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| December 22, 2021 |
Tenet and USPI Complete Transaction to Acquire SCD EX-99.1 2 d278928dex991.htm EX-99.1 Exhibit 99.1 Tenet and USPI Complete Transaction to Acquire SCD DALLAS – Dec. 22, 2021 – Tenet Healthcare Corporation (NYSE: THC) and its subsidiary United Surgical Partners International (USPI) today completed their previously announced transaction to acquire SurgCenter Development (SCD). In connection with the closing of the transaction, Tenet/USPI acquired SC |
|
| December 22, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 22, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emp |
|
| December 1, 2021 |
Exhibit 10.1 TENET HEALTHCARE CORPORATION $1,450,000,000 4.375% Senior Secured First Lien Notes due 2030 unconditionally guaranteed as to the payment of principal, premium, if any, and interest by the Guarantors named on Schedule I hereto Exchange and Registration Rights Agreement December 1, 2021 Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 As Representative of the Initial Purchaser |
|
| December 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 1, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| December 1, 2021 |
Exhibit 4.2 TENET HEALTHCARE CORPORATION AND THE GUARANTORS FROM TIME TO TIME PARTY HERETO Thirty-Eighth Supplemental Indenture Dated as of December 1, 2021 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 4.375% Senior Secured First Lien Notes Due 2030 TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OTHER PROVISIONS |
|
| November 16, 2021 |
Tenet Announces Pricing of its $1.450 Billion Private Offering of Senior Secured Notes Exhibit 99.2 Tenet Announces Pricing of its $1.450 Billion Private Offering of Senior Secured Notes DALLAS ? Nov. 16, 2021 ? Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.450 billion in aggregate principal amount of senior secured first lien notes due on January 15, 2030, which will be |
|
| November 16, 2021 |
Tenet Announces $1.450 Billion Private Offering of Senior Secured Notes EX-99.1 2 d260541dex991.htm EX-99.1 Exhibit 99.1 Tenet Announces $1.450 Billion Private Offering of Senior Secured Notes DALLAS – Nov. 16, 2021 – Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.450 billion in aggregate principal amount of newly issued senior secured first lien notes maturing in 2030 (the “notes”). Completion of the offering is subject to |
|
| November 16, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 16, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emp |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 9, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| November 8, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 8, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| November 8, 2021 |
Tenet and USPI to Acquire SurgCenter Development and Establish Long-Term Development Partnership Exhibit 99.1 Tenet and USPI to Acquire SurgCenter Development and Establish Long-Term Development Partnership ?Acquiring ownership interests in 92 ambulatory surgery centers ?Includes formation of five-year partnership and development agreement between USPI and SCD to provide continuity for SCD platform and future de novo development projects ?Builds on USPI?s position as a leading ambulatory surg |
|
| October 29, 2021 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2021 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| October 29, 2021 |
Certification of Saumya Sutaria, M.D., Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Saumya Sutaria, certify that: 1. |
|
| October 20, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 20, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| October 20, 2021 |
Tenet Reports Third Quarter 2021 Results; Raises 2021 Financial Guidance Exhibit 99.1 Tenet Reports Third Quarter 2021 Results; Raises 2021 Financial Guidance ?Net income from continuing operations available to common shareholders in Q3?21 of $448 million versus a net loss from continuing operations of $197 million in Q3?20 ?Consolidated Adjusted EBITDA in Q3?21 of $855 million ($851 million excluding $4 million of COVID stimulus grant income) versus $551 million in Q3 |
|
| September 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 31, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Emp |
|
| September 3, 2021 |
Exhibit 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into to be effective from and following September 1, 2021 (the ?Effective Date?), between Tenet Healthcare Corporation (the ?Company?) and Saumya Sutaria (?Executive?). W I T N E S S E T H WHEREAS, the Company and Executive are party to that certain Employment |
|
| September 3, 2021 |
Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is hereby entered into to be effective from and following September 1, 2021 (the ?Effective Date?), between Tenet Healthcare Corporation (the ?Company?) and Ronald A. Rittenmeyer (?Executive?). W I T N E S S E T H WHEREAS, the Company and Executive are party to that certain Empl |
|
| August 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 5, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| August 10, 2021 |
Exhibit 99.1 Tenet Announces Leadership Transition Saum Sutaria appointed Chief Executive Officer; Ron Rittenmeyer remains Executive Chairman of Tenet DALLAS ? Aug. 9, 2021 ? Tenet Healthcare Corporation (NYSE: THC) today announced the next step in its long-term leadership succession plan. Ron Rittenmeyer, who has served as CEO and Executive Chairman for nearly four years, will continue as Executi |
|
| August 2, 2021 |
Tenet Completes Sale of Five Hospitals in the Miami-Dade/Southern Broward Area Exhibit 99.1 Tenet Completes Sale of Five Hospitals in the Miami-Dade/Southern Broward Area DALLAS ? August 2, 2021 ? Tenet Healthcare Corporation (NYSE: THC) today announced that it has completed the sale of its five hospitals and related operations in the Miami-Dade and Southern Broward counties. The transaction includes Coral Gables Hospital, Florida Medical Center, Hialeah Hospital, North Shor |
|
| August 2, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 1, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employ |
|
| July 30, 2021 |
Certification of Ronald A. Rittenmeyer, Executive Chairman and Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Ronald A. Rittenmeyer, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under |
|
| July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2021 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| July 30, 2021 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| July 21, 2021 |
Tenet Reports Second Quarter 2021 Results; Raises 2021 Financial Guidance Exhibit 99.1 Tenet Reports Second Quarter 2021 Results; Raises 2021 Financial Guidance ?Net income from continuing operations available to common shareholders in Q2?21 of $120 million versus net income from continuing operations of $88 million in Q2?20 ?Consolidated Adjusted EBITDA in Q2?21 of $834 million ($810 million excluding $24 million of COVID stimulus grant income) versus $732 million in Q |
|
| July 21, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 21, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| June 21, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A Amendment No. |
|
| June 16, 2021 |
Exhibit 99.1 STEWARD HEALTH CARE TO ACQUIRE FIVE HOSPITALS IN THE MIAMI-DADE/SOUTHERN BROWARD AREA FROM TENET HEALTHCARE Acquisition of Tenet hospitals and hospital-affiliated operations will bring greater access to high-quality care in South Florida DALLAS, TX (June 16, 2021) ? Today, Steward Health Care System, LLC (Steward) and Tenet Healthcare Corporation (NYSE: THC) announced that they have s |
|
| June 16, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 16, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| June 2, 2021 |
Exhibit 10.1 Execution Version TENET HEALTHCARE CORPORATION $1,400,000,000 4.250% Senior Secured First Lien Notes due 2029 unconditionally guaranteed as to the payment of principal, premium, if any, and interest by the Guarantors named on Schedule I hereto Exchange and Registration Rights Agreement June 2, 2021 Barclays Capital Inc. 745 Seventh Avenue New York, NY 10019 As Representative of the In |
|
| June 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 2, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 2, 2021 |
Exhibit 4.2 Execution Version TENET HEALTHCARE CORPORATION AND THE GUARANTORS FROM TIME TO TIME PARTY HERETO Thirty-Seventh Supplemental Indenture Dated as of June 2, 2021 (Supplemental Indenture to Indenture Dated as of November 6, 2001) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee 4.250% Senior Secured First Lien Notes Due 2029 TABLE OF CONTENTS Page ARTICLE ONE DEFINITIONS AND OT |
|
| May 18, 2021 |
Tenet Announces $1.4 Billion Private Offering of Senior Secured Notes Exhibit 99.1 Tenet Announces $1.4 Billion Private Offering of Senior Secured Notes DALLAS ? May 18, 2021 ? Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.4 billion in aggregate principal amount of newly issued senior secured first lien notes maturing in 2029 (the ?notes?). Completion of the offering is subject to, among other things, pricing and standar |
|
| May 18, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 18, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employer |
|
| May 18, 2021 |
Tenet Announces Pricing of its $1.4 Billion Private Offering of Senior Secured Notes Exhibit 99.2 Tenet Announces Pricing of its $1.4 Billion Private Offering of Senior Secured Notes DALLAS ? May 18, 2021 ? Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.4 billion in aggregate principal amount of senior secured first lien notes due on June 1, 2029, which will bear intere |
|
| May 12, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 6, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employe |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2021 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number 1-7293 TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 95-2557091 (State of Incorporation) (IRS Employer Identification No. |
|
| April 30, 2021 |
Certification of Daniel J. Cancelmi, Executive Vice President and Chief Financial Officer Exhibit 31(b) Rule 13a-14(a)/15d-14(a) Certification I, Daniel J. Cancelmi, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| April 30, 2021 |
Certification of Ronald A. Rittenmeyer, Executive Chairman and Chief Executive Officer Exhibit 31(a) Rule 13a-14(a)/15d-14(a) Certification I, Ronald A. Rittenmeyer, certify that: 1.I have reviewed this quarterly report on Form 10-Q of Tenet Healthcare Corporation (the “Registrant”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under |
|
| April 23, 2021 |
Exhibit 10.1 Execution Version AMENDMENT NO. 6 This AMENDMENT NO. 6, dated as of April 19, 2021 (together with all exhibits and schedules hereto, this ?Amendment?) to that certain Amended and Restated Credit Agreement, dated as of October 19, 2010 (as amended, restated, amended and restated, supplemented or otherwise modified through the date hereof, the ?Existing Credit Agreement?) among Tenet He |
|
| April 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 19, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Empl |
|
| April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11)* TENET HEALTHCARE CORPORATION (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of Securities) 88033G407 (CUSIP Number) Mark Horowitz Co-President Glenview Capital Management 767 Fifth Avenue, 44th Floor New York, NY 10153 (212) 81 |
|
| April 22, 2021 |
CUSIP No. 88033G407 Page 8 of 9 Pages EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Tenet Healthcare Corporation dated as of April 22, 2021 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance |
|
| April 22, 2021 |
CUSIP No. 88033G407 Page 9 of 9 Pages EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENT, that I, Larry Robbins, hereby make, constitute and appoint Mark J. Horowitz, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as Chief Executive Officer or in other capacities of Glenview Capital Management, |
|
| April 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TENET HEALTHCARE CORPORATION (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of Securities) 88033G407 (CUSIP Number) April 21, 2021** (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate t |
|
| April 20, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 20, 2021 (Date of earliest event reported) TENET HEALTHCARE CORPORATION (Exact name of Registrant as specified in its charter) Nevada 1-7293 95-2557091 (State of Incorporation) (Commission File Number) (IRS Employer Identification Number) 14201 Dallas Parkway Dallas, TX 75254 (Address of principal executive offices, including zip code) (469) 893-2200 (Registrant?s telephone number, including area code) Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0. |
|
| April 20, 2021 |
Tenet Reports First Quarter 2021 Results; Raises 2021 Financial Guidance Exhibit 99.1 Tenet Reports First Quarter 2021 Results; Raises 2021 Financial Guidance •Net income from continuing operations available to common shareholders in 1Q21 of $97 million versus net income from continuing operations of $94 million in 1Q20; the 2020 quarter included a $91 million income tax benefit associated with a change in the deductibility of interest expense •Consolidated Adjusted EB |
|
| March 26, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| March 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
